Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Oculus Innovative Sciences Inc Receives CE Mark for use of Microcyn

Tuesday, 4 Feb 2014 08:08am EST 

Oculus Innovative Sciences Inc:Receives the European CE Mark for the Microcyn -based GramaDerm Solution and GramaDerm Hydrogel.Both products are intended for use in the topical treatment of mild to moderate acne and are designed to complement other acne treatments. 

Company Quote

-0.01 -0.67%
26 Dec 2014